CARM: Rega marang dodolan Carisma Therapeutics Inc
Carisma Therapeutics (CARM) revenue valuation demonstrates volatility amid a fierce battle for leadership in oncotherapy, a sector dominated by resource-rich behemoths. Meanwhile, 0.60 represents the latest metric reading, highlighting the dependence of Carisma Therapeutics (CARM) on external contract manufacturing organizations. Stability is provided by the unique CAR-M platform, which creates a closed patent perimeter and ties clinics to long-term treatment protocols.
Rincian analitis perusahaan Carisma Tx (CARM)
- rega saham lan target rega konsensus:
- informasi kapitalisasi pasar:
- data nilai buku modal saham:
- statistik kawajiban utang lan likuiditas:
Rasio Kabeh Utang marang Dana Pribadi Carisma Therapeutics|CARM - Utang jangka dawa marang modal|Koefisien utang jangka cendhak marang modal Carisma Therapeutics Inc|CARM - Utang perusahaan|Utang-utang marang aset resik Carisma Therapeutics|CARM - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Carisma Therapeutics|Rasio cepet carismatx.com
- data bathi bisnis lan rasio investasi:
CARM - Penghasilan resik|Penghasilan resik sing dikarepake Carisma Therapeutics|CARM - Koefisien rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep Carisma Therapeutics Inc.|CARM - Pangali PEG|Nilai bisnis marang bathi operasional sadurunge panyusutan CARM|CARM - Bathi operasional EBITDA|Bathi resik saben siji saham sajrone rolas wulan pungkasan Carisma Therapeutics|CARM - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan carismatx.com|CARM - Wutah bathi ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Carisma Therapeutics
- rincian pendapatan lan dodolan emiten:
Analisis fundamental perusahaan:CARM, Carisma Therapeutics
Carisma Therapeutics (CARM) utilizes external CDMO facilities to scale the production of immunotherapies, thereby minimizing capital expenditures. The company's current P/S ratio compares total market capitalization to generated revenue, revealing the actual value of each dollar of sales. This chart's price action allows for the separation of market euphoria from fundamental business performance metrics. Extreme indicator values signal either a critical overheating of the asset or a systemic decline in demand.
Pesaing Carisma Therapeutics
argenx - Rasio kapitalisasi marang pendapatan|Multiplikator P/S BNTX (biontech.de)|Abivax Corp (ABVX) - Rega marang dodolan|ADMA Corp - Multiplikator P/S|Rasio rega marang dodolan PTGX|Immunovant Inc (IMVT) - Rasio rega marang pendapatan|KNSA - Koefisien rega marang pendapatan|GRFS (Grifols Biemat) - Multiplikator P/S|Multiplikator P/S Adaptive Biotechnologies Inc.|Rasio rega marang pendapatan Celldex Therapeutics (CLDX)|Koefisien rega marang pendapatan auriniapharma.com|Rasio rega marang pendapatan BioCryst Pharmaceuticals BCRX|Rasio kapitalisasi pasar marang pendapatan VERA|Dianthus Pharma - Multiplikator P/S|PHVS - Multiplikator P/S|ABCL: Multiplikator P/S|TRML (Tourmaline Bio, Inc.) - Rasio rega marang pendapatan|Rasio rega marang pendapatan Intrexon|PHAR - Multiplikator rega marang pendapatan|Multiplikator P/S NKTR|Rasio rega marang pendapatan UPB (Upstream Bio Corp)|Rasio rega marang pendapatan Zenas Biopharma, Inc. ZBIO|Koefisien rega marang pendapatan immunome.com (IMNM)|Gossamer Bio Inc - Multiplikator P/S|Rasio kapitalisasi pasar marang pendapatan KALV (KalVista Pharmaceuticals, Inc.)|SEPN: Multiplikator P/S|Kapitalisasi marang pendapatan Pieris Pharmaceuticals Inc|Kapitalisasi marang pendapatan SVRA|Kapitalisasi marang pendapatan Rigel Pharmaceuticals (RIGL)|Multiplikator P/S ANAB|ATXS - Rega marang dodolan|Rasio rega marang pendapatan enGene Corp ENGN|Koefisien rega marang pendapatan RAPT Therapeutics, Inc. (RAPT)|Aerovate - Multiplikator P/S|ACRS - Multiplikator P/S|KYTX (Kyverna Therapeutics) - Kapitalisasi marang pendapatan|Rega marang dodolan Tiziana Life Sciences Ltd. (TLSA)|Kapitalisasi marang pendapatan CABA|Ventyx Biosciences (VTYX) - Koefisien rega marang pendapatan|Multiplikator P/S THTX|AVTX (Avalo Therapeutics, Inc) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S ELDN (eledon.com)|AGEN - Kapitalisasi marang pendapatan|CLYM - Rasio rega marang pendapatan|Rasio rega marang dodolan ZURA|ATYR: Multiplikator P/S|Adagene Corp (ADAG) - Multiplikator P/S|Kapitalisasi marang pendapatan IMA|Shattuck Labs, Inc. - Rasio rega marang dodolan|Rasio rega marang pendapatan Equillium Inc (EQ)|Multiplikator P/S Connect Biopharma Holdings (CNTB)|Rasio rega marang pendapatan Immunic, Inc. IMUX|Multiplikator P/S Atara Biotherapeutics ATRA|IFRX - Rasio rega marang pendapatan|XFOR: Rasio rega marang pendapatan|ACET: Multiplikator P/S|CELU - Koefisien rega marang pendapatan|Rasio rega marang pendapatan inmunebio.com|Rasio kapitalisasi marang pendapatan BRNS (barinthusbio.com)|Multiplikator P/S KZR|Multiplikator P/S SAB Biotherapeutics, Inc (SABS)|Multiplikator P/S AKTX (Akari Therapeutics, Plc)|Multiplikator P/S enlivex.com ENLV|QTTB: Kapitalisasi marang pendapatan|GOVX - Multiplikator P/S|Edesa Biotech Inc (EDSA) - Rasio rega marang pendapatan|IBIO - Koefisien rega marang pendapatan|Kapitalisasi marang pendapatan XTLB|Kapitalisasi marang pendapatan boltbio.com (BOLT)|Rasio rega marang pendapatan HCW Biologics Inc (HCWB)|Multiplikator P/S Aptevo Therapeutics, Inc. (APVO)|Rasio rega marang pendapatan aimimmuno.com AIM|Rasio kapitalisasi pasar marang pendapatan ADTX|GRI Bio Corporation - Multiplikator P/S|XORTX Corp (XRTX) - Kapitalisasi marang pendapatan|HIND (Vyome Holdings Inc.) - Kapitalisasi marang pendapatan|revbiosciences.com (REVB) - Multiplikator P/S|INDP (Indaptus Corp) - Multiplikator P/S|Kapitalisasi marang pendapatan Scinai Immunotherapeutics Ltd (SCNI)|Rasio rega marang pendapatan CalciMedica Inc (CALI)|AFMD (Affimed NV) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S ALLK (Allakos Inc.)|Multiplikator P/S HOOKIPA HOOK|IGMS: Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan ITOS (iTeos)|OCEA: Multiplikator P/S|TCBP (TC BioPharm Ltd) - Rasio rega marang pendapatan|THRD (Third Harmonic Bio Inc) - Multiplikator P/S
